Navigation Links
Aratana Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Date:9/27/2013

KANSAS CITY, Kan. and BOSTON, Sept. 27, 2013 /PRNewswire/ -- Aratana Therapeutics (Nasdaq:  PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets (pet therapeutics), today announced that it will present at the BioCentury's NewsMakers in the Biotech Industry Conference to be held September 27, 2013, at the Millennium Broadway Hotel in New York City.

Steven St. Peter, M.D., President and Chief Executive Officer, will provide an overview of the Company's business during his live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences. Event:BioCentury's NewsMakers in the Biotech Industry ConferenceDate: Friday, September 27, 2013 Time: 10:30 a.m. (Eastern Time) Location:Millennium Broadway Hotel 145 W. 44th Street; New YorkAbout Aratana Therapeutics
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets.  For more information, please visit www.aratana.com.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)
jdrumm@tiberend.com; (212) 375-2664

Andrew Mielach (media)
amielach@tiberend.com; (212) 375-2694


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Therapeutics Drives Awareness of Pet Therapeutic Opportunity During "CVC Week" in Kansas City
2. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
3. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
4. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
6. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
7. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
8. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
9. Aratana to Participate in Leerink Swanns November Management Access Days
10. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
11. PTC Therapeutics to Present at World Muscle Society Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... , ... Cosmetic Town, an online plastic surgery community, begins 2017 with an ... for their readers to get the information they desire. The procedures are now listed ... used on those particular areas. , “We are excited to streamline our listings in ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... certified dermatologist by the American Board of Dermatology and fellowship trained Mohs and ... the National Institutes of Health, Dr. Li completed his internship in internal medicine ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... doctor who administered fillers that resulted in severe facial disfiguration. After four frightening ... on by doctors at UCLA Medical Center, who removed the substances in a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and privacy panel system. , The Tranquility privacy panel system was designed ... office environment. Tranquility panels help reduce noise and provide the visual privacy required ...
Breaking Medicine News(10 mins):